Insider Trading History of Knudson Mark B

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Knudson Mark B since 2005. The trader's CIK number is 1243513. At the time of the last reporting, Knudson Mark B was the Chrmn, Pres & CEO of Reshape Lifesciences Inc.. (stock ticker symbol RSLS). Also see all insider trading activities at Reshape Lifesciences Inc..

Note that in the past KNUDSON MARK B also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Reshape Lifesciences Inc. (ETRM) by Knudson Mark B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 ETRM 613,000 $124,682 0 $0 0 $0
2010 ETRM 25,000 $43,500 0 $0 0 $0
2009 ETRM 65,979 $75,875 0 $0 0 $0
2008 ETRM 1,000 $1,708 0 $0 0 $0

Yearly summary of insider trading at Diametrics Medical Inc (DMED) by Knudson Mark B

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 DMED 0 $0 0 $0 0 $0


Insider trading activities at 2 companies by Knudson Mark B:

1. Reshape Lifesciences Inc. (ETRM)

2. Diametrics Medical Inc (DMED)

Table 1. Insider trading of Reshape Lifesciences Inc. (ETRM) by Knudson Mark B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-11-12 ETRM Buy 310,000 .16 49,910
2015-08-13 ETRM Buy 168,000 .25 41,832
2015-08-12 ETRM Buy 135,000 .24 32,940
2010-12-09 ETRM Buy 25,000 1.74 43,500
2009-02-24 ETRM Buy 65,979 1.15 75,875
2008-11-17 ETRM Buy 848 1.75 1,484
2008-11-14 ETRM Buy 152 1.48 224

Table 2. Insider trading of Diametrics Medical Inc (DMED) by Knudson Mark B

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-12-02 DMED Sale 0 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Knudson Mark B (Chrmn, Pres & CEO of Reshape Lifesciences Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.